Search Results for “E_S4HCON2023 Übungsmaterialien – E_S4HCON2023 Lernführung: SAP Certified Technology Specialist – SAP S/4HANA Conversion and SAP System Upgrade – E_S4HCON2023 Lernguide ♿ Suchen Sie auf ⏩ www.itzert.com ⏪ nach 《 E_S4HCON2023 》 und erhalten Sie den kostenlosen Download mühelos 🕑E_S4HCON2023 Online Prüfung” – Page 50

What are the most promising strategies for the therapeutic immunomodulation of allergic diseases?

3.	Tokura, Y., Röcken, M., Clark, R. A. F., Maurer, M., Grabbe, S., Haliasos, E., Takigawa M., and Sinha, A. A.: What are the most promising strategies for the therapeutic immunomodulation of allergic diseases? Exp. Dermatol. 2001: 11; 128-140. IF: 2.23

A mutation in the kringle domain of human factor XII that causes autoinflammation, disturbs zymogen quiescence and accelerates activation

371

Hofman, Z. L. M.*, Clark, C. C.*, Sanrattana, W., Nosairi, A., Parr, N., Zivkovic, M., Krause, K., Mahnke, N. A., Scheffel, J., Hack, C. E., Maurer, M., de Maat, S., and Maas, C.+: A mutation in the kringle domain of human factor XII that causes autoinflammation, disturbs zymogen quiescence and accelerates activation. J. Biol. Chem. 2020: 295; 363-374. IF: 5.16

o.371

74.	Schoepke, N., Doumoulakis, G., and Maurer, M.: Diagnosis of urticaria. Ind. J. Dermatology 2013: 58; 211-218. IF: N/A

155	Cai, Y., Folkerts, J., Folkerts, G., Maurer, M., and Braber, S.+: Microbiota-dependent and –independent effects of dietary fiber on human health. Brit. J. Pharmacol. 2020: 177; 1363-1381. IF: 8.74

r.155

154	Kolkhir, P., Altrichter, S., Muñoz, M., Hawro, T., and Maurer, M.+: New treatments for chronic urticaria. Ann. Allergy Asthma Immunol. 2020: 124; 2-12. IF: 6.35

r.154

45.	Maurer, M. and Magerl, M.: Hereditary angioedema: an update on available therapeutic options. J. Dtsch. Dermatol. Ges. 2010: 8; 663-672. IF: 1.48

From seafood waste to active seafood packaging: an emerging opportunity of the circular economy

149

De la Caba, K., Guerrero, P., Si Trung, T., Cruz-Romero, M., Kerry, J. P., Fluhr, J., Maurer, M., Kruijssen, F., Albalat, A., Bunting, S., Burt, S., Little, D., and Newton, R.: From seafood waste to active seafood packaging: an emerging opportunity of the circular economy. J. Clean. Prod. 2019: 208; 86-98. IF: 7.25

r.149

Efficacy and safety of Dupilumab for moderate-to-severe atopic dermatitis: a systematic review for the EAACI biologicals guidelines

411.

Agache, I.⁺, Song, Y., Posso, M., Alonso-Coello, P., Rocha, C., Solà, I., Beltran, J., Akdis, C., Akdis, M., Brockow, K., Chivato, T., del Giacco, S., Eiwegger, T., Eyerich, K., Giménez-Arnau, A., Gutermuth, J., Guttman-Yassky, E., Maurer, M., Ogg, G., Ong, P. Y., O’Mahony, L., Schwarze, J., Werfel, T., Canelo-Aybar, C.*, Palomares, O.*, and Jutel, M.*: Efficacy and safety of Dupilumab for moderate-to-severe atopic dermatitis: a systematic review for the EAACI biologicals guidelines. Allergy 2021: 76; 45-58. IF: 14.71

o.411

Rupatadine in established treatment schemes improves chronic spontaneous urticaria symptoms and patients’ quality of life: a prospective, non-interventional trial

229

Metz, M., Weller, K., Neumeister, C., Izquierdo, I., Bödeker, R. H., Schwantes, U.+, and Maurer, M.:Rupatadine in established treatment schemes improves chronic spontaneous urticaria symptoms and patients’ quality of life: a prospective, non-interventional trial. Dermatol. Ther. 2015: 5; 217-230. IF: 1.26

Skin microdialysis: methods, applications and future opportunities – an EAACI position paper

144.

Baumann, K. Y., Church, M. K., Clough, G. F., Quist, S., R., Schmelz, M., Stahl Skov, P., Anderson, C. D., Kring Tannert, L., Giménez-Arnau, A. M., Frischbutter, S., Scheffel, J., and Maurer, M.+: Skin microdialysis: methods, applications and future opportunities – an EAACI position paper. Clin. Transl. Allergy 2019: 9; 24. IF: 5.13

r.144